Peetz Christopher 的 Form 4 申報
Mirum Pharmaceuticals, Inc.（MIRM），2026/6/2 申報
- 申報編號
- 0001614740-26-000010
- 申報時間
- 2026/6/2
- 交易日
- 2026/6/1
- 申報延遲
- 1 天
- 10b5-1 計畫
- 有勾選
這份申報列了 7 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $287.5 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Peetz ChristopherCIK 0001614740 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/1 | Common Stock | M行使選擇權取得 | +30,000 | $2.94 | +$88,200 | 224,309 | 直接 | |
| 2026/6/1 | Common Stock | S賣出處分 | −2,602 | $94.64F2 | −$246,253.28 | 221,707 | 直接 | |
| 2026/6/1 | Common Stock | S賣出處分 | −16,595 | $95.34F3 | −$1,582,167.3 | 205,112 | 直接 | |
| 2026/6/1 | Common Stock | S賣出處分 | −6,926 | $96.15F4 | −$665,934.9 | 198,186 | 直接 | |
| 2026/6/1 | Common Stock | S賣出處分 | −1,973 | $97.56F5 | −$192,485.88 | 196,213 | 直接 | |
| 2026/6/1 | Common Stock | S賣出處分 | −1,021 | $98.20F6 | −$100,262.2 | 195,192 | 直接 | |
| 2026/6/1 | Common Stock | S賣出處分 | −883 | $99.66F7 | −$87,999.78 | 194,309 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/6/1 | Common Stock | M行使選擇權處分 | −30,000 | $0.00 | $0 | 128,487 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction reported was $94.64, and the range of prices were between $93.90 and $94.895. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The weighted average sale price for the transaction reported was $95.34, and the range of prices were between $94.91 and $95.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $96.15, and the range of prices were between $95.92 and $96.8675. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $97.56, and the range of prices were between $96.98 and $97.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The weighted average sale price for the transaction reported was $98.20, and the range of prices were between $98.00 and $98.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The weighted average sale price for the transaction reported was $99.66, and the range of prices were between $99.55 and $99.79. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。